Acute exacerbation of COPD: Nursing application of evidence-based guidelines

Critical Care Nursing Quarterly

Volumn 27, Issue 4, 2004, Pages 336-352

  Gronkiewicz, Cynthia ^c   Borkgren Okonek, Marilyn ^a,b  

^a Suburban Lung Associates   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NONE   (United States)

Author keywords

Acute exacerbation; COPD; Oxygen therapy; Pharmacotherapy; Pulmonary rehabilitation

Indexed keywords

AMINOPHYLLINE; ANTIBIOTIC AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; IPRATROPIUM BROMIDE; LEVALBUTEROL; MACROLIDE; METHYLPREDNISOLONE; METHYLXANTHINE DERIVATIVE; PHENYTOIN; PIRBUTEROL; PREDNISONE; QUINOLONE DERIVATIVE; SALBUTAMOL; SALMETEROL; STEROID; TERBUTALINE; THEOPHYLLINE; TIOTROPIUM BROMIDE; TRIAMCINOLONE; UNINDEXED DRUG;

ACID BASE BALANCE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE EXACERBATION; EVIDENCE BASED MEDICINE; EXCITABILITY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH PROMOTION; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; INFECTION; MENTAL DISEASE; NAUSEA; NURSING; OXYGEN THERAPY; PATIENT EDUCATION; PRACTICE GUIDELINE; REVIEW; SEIZURE; SIDE EFFECT; SKIN DISEASE; TACHYCARDIA; TREMOR; UNITED STATES; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 6344272491     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002727-200410000-00005     Document Type: Review

References (49)

1. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1256-1276.
2. Snow V, Lascher S, Mottur-Pilson C. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2001;134:595-599.
3. Bach PB, Brown C, Gelfand BA, McCrory DC. Management of acute exacerbation of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med. 2001;134:600-620.
4. McCrory DC, Brown C, Gelland SE, Bach PB. Management of acute exacerbations of COPD: a summary and appraisal of published evidence. Chest. 2001;119:1190-1209.
5. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2000;343(4):269-278.
6. Cleverley JR, Muller NL. Advances in radiologic assessment of chronic obstructive pulmonary disease. Clin Chest Med. 2000;21(4):653-663.
7. Heffner JE, Highland KB. Chronic obstructive pulmonary disease in geriatric critical care. Crit Care Clin. 2003;19:713-727.
8. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Resp Crit Care Med. 1996;154:959-967.
9. Ferguson GT. Update on pharmacologic therapy for chronic obstructive pulmonary disease. Clin Chest Med. 2000;21(4):723-738.
10. Bullard MJ, Liaw S, Tsai Y, Min HP. Early corticosteroid use in acute exacerbations of chronic air-flow obstruction. Am J Emerg Med. 1996;14(2):139-143.
11. McEvoy CE, Niewoehner DE. Corticosteroids in chronic obstructive pulmonary disease: clinical benefits and risks. Clin Chest Med. 2000;21(4):739-752.
12. Miravitlles M, Espinosa C, Fernandez-Laso E, et al, and the study group of bacterial infections in COPD. Relationship between flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest. 1999;116:40-46.
13. Sherk PA, Grossman RF. The chronic obstructive disease exacerbation. Clin Chest Med. 2000;21(4):705-721.
14. Hill NS. Noninvasive ventilation in chronic obstructive pulmonary disease. Clin Chest Med. 2000;21(4): 783-797.
15. Nevins ML, Epstein SK. Predictors of outcomes for patients with COPD requiring invasive mechanical ventilation. Chest. 2001;119:1840-1849.
16. Pouw EM, Ten Velde GPM, Croonen BHPM, Rester ADM, Schols AMWJ, Wouters EFM. Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss. Clin Nutr. 2000;19:95-99.
17. Schols AMWJ, Wouters EFM. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease. Clin Chest Med. 2000;21(4):753-762.
18. Sheth SG, LaMont JT. Gastrointestinal problems in the chronically critically ill patient. Clin Chest Med. 2001;22(1):135-147.
19. Geerts W, Heit J, Clagett G. Prevention of venous thromboembolism. Chest. 2001;119(S):S132-S135.
20. Wunderlink RG. "Tis a gift to be simple...." Chest. 2003;124(3):777-778.
21. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet. 1999;354:1851-1858.
22. Seemungal T, Donaldson G, Bhowmik A, Jeffries D, Wedzicha J. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1608-1613.
23. Cote CG, Celli BR. Answers to nine key questions on COPD. Contemp Intern Med. 1998;10(3):9-15.
24. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in chronic obstructive lung disease. Ann Intern Med. 1980;93:391-398.
25. American Thoracic Society Statement: standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152S:77-121.
26. Tarpy SP, Celli BR. Long-term oxygen therapy. N Engl J Med. 1995;333:710-714.
27. Dougherty JA, Didur BL, Aboussouan LS. Long-acting inhaled beta2 agonists for stable COPD. Ann Pharmacother. 2003;37(9):1247-1255
28. Tashkin D, Cooper C. The role of long-acting bronchodilators in the management of stable COPD. Chest. 2004;125:249-259.
29. Sin D, McAlister F, Man SF, Anthonisen N. Contemporary management of chronic obstructive pulmonary disease: a scientific review. JAMA. 2003;290:2301-2312.
30. Brusasco y Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax. 2003;58:399-404.
31. Tashkin D, Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest. 2003;123:1441-1449.
32. Combivent Inhalation Aerosol Study Group. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: an 85-day multicenter trial. Chest. 1994;105:1411-1419.
33. Ram F, Jones P, Castro A, et al. Oral theophylline for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002;4:CD003902.
34. Soriano J, Kiri V, Pride N, Vestbo J. Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patients. Am J Respir Med. 2003;2:67-74.
35. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. A clinical practice guideline for treating tobacco use and dependence. JAMA. 2000;283:244-254.
36. Jorenby D, Leischow S, Nides M, et al. Effect of sustained-release bupropion, a nicotine patch or their combination for smoking cessation. N Engl J Med. 1999;340:685-691.
37. Stitzer M, Walsh SL. Psychostimulant abuse: the case for combined behavioral and pharmacological treatments. Pharmacol Biochem Behav. 1997;57:457-470.
38. Centers for Disease Control. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1999;48:1-28.
39. Centers for Disease Control. Prevention and control of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46:1-24.
40. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:58-164.
41. Nishimura K, Izumi T, Tsukino O, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434-1440.
42. Hansen-Flaschen J. Chronic obstructive pulmonary disease: the last year of life. Respir Care. 2004;49:90-97.
43. Make B. Pulmonary rehabilitation. In: Baum's Textbook of Pulmonary Diseases. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
44. Salman G, Mosier M, Beasley M, Calkins D. Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials. J Gen Intern Med. 2003;18:213-221.
45. Bourjeily G, Rochester C. Exercise training in chronic obstructive pulmonary disease. Clin Chest Med. 2000;21:763-781.
46. Pulmonary rehabilitation-1999. The official statement of the American Thoracic Society. Am J Respir Crit Care Med. 1999;159:1666-1682.
47. Cahalin L, Braga M, Matsuo Y, Hernandez E. Efficacy of diaphragmatic breathing in persons with chronic obstructive pulmonary disease: a review of the literature. J Cardiopulm Rehabil. 2002;22:7-21.
48. Letters F, van Tol B, Kwakkel G, Gosselink R. Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur Respir J. 2002;20:550-576.
49. Larson J, Covey M, Wirtz S, et al. Cycle ergometry and inspiratory muscle training in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;190:500-507.